Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Digital Diabetes Management Market, by Type
1.4.2 Asia Pacific Digital Diabetes Management Market, by Product & Service
1.4.3 Asia Pacific Digital Diabetes Management Market, by End User
1.4.4 Asia Pacific Digital Diabetes Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Business Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Jun – 2022, Apr) Leading Players
Chapter 4. Asia Pacific Digital Diabetes Management Market by Type
4.1 Asia Pacific Wearables Market by Country
4.2 Asia Pacific Handheld Devices Market by Country
Chapter 5. Asia Pacific Digital Diabetes Management Market by Product & Service
5.1 Asia Pacific Devices Market by Country
5.2 Asia Pacific Digital Diabetes Management Market by Devices Type
5.2.1 Asia Pacific Continuous Glucose Monitoring (CGM) Systems Market by Country
5.2.2 Asia Pacific Smart Glucose Meters Market by Country
5.2.3 Asia Pacific Smart Insulin Pens Market by Country
5.2.4 Asia Pacific Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches Market by Country
5.3 Asia Pacific Application Market by Country
5.4 Asia Pacific Digital Diabetes Management Market by Application Type
5.4.1 Asia Pacific Diabetes & Blood Glucose Tracking Apps Market by Country
5.4.2 Asia Pacific Obesity & Diet Management Apps Market by Country
5.5 Asia Pacific Data Management Software & Platforms Market by Country
5.6 Asia Pacific Services Market by Country
Chapter 6. Asia Pacific Digital Diabetes Management Market by End User
6.1 Asia Pacific Self/Home Healthcare Market by Country
6.2 Asia Pacific Hospitals & Specialty Diabetes Clinics Market by Country
6.3 Asia Pacific Academic & Research Institutes Market by Country
Chapter 7. Asia Pacific Digital Diabetes Management Market by Country
7.1 China Digital Diabetes Management Market
7.1.1 China Digital Diabetes Management Market by Type
7.1.2 China Digital Diabetes Management Market by Product & Service
7.1.2.1 China Digital Diabetes Management Market by Devices Type
7.1.2.2 China Digital Diabetes Management Market by Application Type
7.1.3 China Digital Diabetes Management Market by End User
7.2 Japan Digital Diabetes Management Market
7.2.1 Japan Digital Diabetes Management Market by Type
7.2.2 Japan Digital Diabetes Management Market by Product & Service
7.2.2.1 Japan Digital Diabetes Management Market by Devices Type
7.2.2.2 Japan Digital Diabetes Management Market by Application Type
7.2.3 Japan Digital Diabetes Management Market by End User
7.3 India Digital Diabetes Management Market
7.3.1 India Digital Diabetes Management Market by Type
7.3.2 India Digital Diabetes Management Market by Product & Service
7.3.2.1 India Digital Diabetes Management Market by Devices Type
7.3.2.2 India Digital Diabetes Management Market by Application Type
7.3.3 India Digital Diabetes Management Market by End User
7.4 South Korea Digital Diabetes Management Market
7.4.1 South Korea Digital Diabetes Management Market by Type
7.4.2 South Korea Digital Diabetes Management Market by Product & Service
7.4.2.1 South Korea Digital Diabetes Management Market by Devices Type
7.4.2.2 South Korea Digital Diabetes Management Market by Application Type
7.4.3 South Korea Digital Diabetes Management Market by End User
7.5 Singapore Digital Diabetes Management Market
7.5.1 Singapore Digital Diabetes Management Market by Type
7.5.2 Singapore Digital Diabetes Management Market by Product & Service
7.5.2.1 Singapore Digital Diabetes Management Market by Devices Type
7.5.2.2 Singapore Digital Diabetes Management Market by Application Type
7.5.3 Singapore Digital Diabetes Management Market by End User
7.6 Malaysia Digital Diabetes Management Market
7.6.1 Malaysia Digital Diabetes Management Market by Type
7.6.2 Malaysia Digital Diabetes Management Market by Product & Service
7.6.2.1 Malaysia Digital Diabetes Management Market by Devices Type
7.6.2.2 Malaysia Digital Diabetes Management Market by Application Type
7.6.3 Malaysia Digital Diabetes Management Market by End User
7.7 Rest of Asia Pacific Digital Diabetes Management Market
7.7.1 Rest of Asia Pacific Digital Diabetes Management Market by Type
7.7.2 Rest of Asia Pacific Digital Diabetes Management Market by Product & Service
7.7.2.1 Rest of Asia Pacific Digital Diabetes Management Market by Devices Type
7.7.2.2 Rest of Asia Pacific Digital Diabetes Management Market by Application Type
7.7.3 Rest of Asia Pacific Digital Diabetes Management Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Business Expansions:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Partnerships, Collaborations, and Agreements:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.5 DexCom, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Novo Nordisk A/S
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental & Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 ACON Laboratories, Inc.
8.7.1 Company Overview
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 B. Braun Melsungen AG
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. Azumio, Inc.
8.10.1 Company Overview